% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Clasen:179375,
author = {J. L. Clasen and A. K. Heath and H. Van Puyvelde and I.
Huybrechts and J. Y. Park and P. Ferrari and G. Scelo and A.
Ulvik and Ø. Midttun and P. M. Ueland and K. Overvad and A.
K. Eriksen and A. Tjønneland and R. Kaaks$^*$ and V.
Katzke$^*$ and M. B. Schulze and D. Palli and C. Agnoli and
P. Chiodini and R. Tumino and C. Sacerdote and R. Zamora-Ros
and M. Rodriguez-Barranco and C. Santiuste and E. Ardanaz
and P. Amiano and J. A. Schmidt and E. Weiderpass and M.
Gunter and E. Riboli and A. J. Cross and M. Johansson and D.
C. Muller},
title = {{B}iomarkers of the transsulfuration pathway and risk of
renal cell carcinoma in the {E}uropean {P}rospective
{I}nvestigation into {C}ancer and {N}utrition ({EPIC})
study.},
journal = {International journal of cancer},
volume = {151},
number = {5},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2022-00626},
pages = {708-716},
year = {2022},
note = {2022 Sep 1;151(5):708-716},
abstract = {Previous studies have suggested that components of
one-carbon metabolism, particularly circulating vitamin B6,
have an etiological role in renal cell carcinoma (RCC).
Vitamin B6 is a cofactor in the transsulfuration pathway. We
sought to holistically investigate the role of the
transsulfuration pathway in RCC risk. We conducted a nested
case-control study (455 RCC cases and 455 matched controls)
within the European Prospective Investigation into Cancer
and Nutrition (EPIC) study. Plasma samples from the baseline
visit were analyzed for metabolites of the transsulfuration
pathway, including pyridoxal 5'-phosphate (PLP, the
biologically active form of vitamin B6), homocysteine,
serine, cystathionine, and cysteine, in addition to folate.
Bayesian conditional logistic regression was used to
estimate associations of metabolites with RCC risk as well
as interactions with established RCC risk factors.
Circulating PLP and cysteine were inversely associated with
RCC risk, and these association were not attenuated after
adjustment for other transsulfuration metabolites (odds
ratio (OR) and $90\%$ credible interval (CrI) per 1 SD
increase in log concentration: 0.76 [0.66, 0.87]; 0.81
[0.66, 0.96], respectively). A comparison of joint
metabolite profiles suggested substantially greater RCC risk
for the profile representative of low overall
transsulfuration function compared with high function (OR
2.70 $[90\%$ CrI 1.26, 5.70]). We found some statistical
evidence of interactions of cysteine with body mass index,
and PLP and homocysteine with smoking status, on their
associations with RCC risk. In conclusion, we found evidence
suggesting that the transsulfuration pathway may play a role
in metabolic dysregulation leading to RCC development. This
article is protected by copyright. All rights reserved.},
keywords = {dietary biomarkers (Other) / kidney cancer (Other) /
transsulfuration (Other) / vitamin B6 (Other)},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:35366005},
doi = {10.1002/ijc.34009},
url = {https://inrepo02.dkfz.de/record/179375},
}